VaxGen Inc. moved one step closer to realizing its proposed merger with Raven Biotechnologies Inc. as shareholders at yesterday's annual meeting re-elected VaxGen's current board of directors and approved a merger-related reverse stock split. (BioWorld Today) Read More
